Floatz logo

Fruquintinib

mCRC

Huazhong University of Science and TechnologySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the mCRC cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
Shanghai Henlius Biotech
Phase 2B
FLUOROURACILUM
Shanghai Henlius Biotech
Phase 2B
Eloxatin
Shanghai Henlius Biotech
Phase 2B
Irinotecan
Oncolytics Biotech
Phase 2CCC
(+)-VINCRISTINE
Oncolytics Biotech
Phase 2CCC

View all 20 →

Same molecule, other indications

Fruquintinib is also rated in:

metastasis from malignant tumor of colonDormant
BBB
Indicative ·
72 / 100
View asset →
colorectal cancerDormant
BB
Indicative ·
67 / 100
View asset →
colorectal cancerDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →